PMID- 31528231 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1837-9664 (Print) IS - 1837-9664 (Electronic) IS - 1837-9664 (Linking) VI - 10 IP - 19 DP - 2019 TI - The long noncoding RNA KCNQ1DN suppresses the survival of renal cell carcinoma cells through downregulating c-Myc. PG - 4662-4670 LID - 10.7150/jca.29280 [doi] AB - Background: Long noncoding RNAs (lncRNAs) have been demonstrated to play essential roles in renal cell carcinoma (RCC). However, the role of lncRNA KCNQ1DN in RCC remains unclear. Methods: The expression of KCNQ1DN in RCC and the corresponding adjacent tissues was measured by qPCR. RNA fluorescence in situ hybridization (FISH) assay, methylation analysis, reporter gene assays and functional tests were performed to reveal the effects of KCNQ1DN on RCC. Results: In the present study, we found that lncRNA KCNQ1DN was notably decreased in RCC tissues and cell lines. RNA FISH assay showed that KCNQ1DN mainly localized to the cytoplasm. Methylation analysis revealed that the proximal region of KCNQ1DN promoter was hypermethylated in RCC tissues relative to the adjacent normal ones. Functional studies clarified that KCNQ1DN repressed the RCC cell growth and cell cycle progression. Mechanistically, KCNQ1DN inhibited the expression of c-Myc, which might further upregulate cyclin D1 and suppress p27 at mRNA and protein levels in RCC cells. Reporter gene assays revealed that the transcriptional activity of c-Myc promoter was inhibited by KCNQ1DN. The in vivo experiments in nude mice showed that KCNQ1DN overexpression dramatically repressed the growth of xenograft tumors and the expression of corresponding c-Myc. Conclusion: These results indicated that KCNQ1DN inhibit the growth of RCC cells in vitro and in vivo through repressing the oncogene c-myc, suggesting that KCNQ1DN may serve as a novel target for the treatment of RCC. FAU - Yang, Fan AU - Yang F AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. AD - Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing 400038, China. FAU - Wu, Qingjian AU - Wu Q AD - Department of Urology, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Zhang, Le AU - Zhang L AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Xie, Wei AU - Xie W AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Sun, Xiaoli AU - Sun X AD - Nursing division, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Zhang, Yan AU - Zhang Y AD - Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing 400038, China. FAU - Wang, Lei AU - Wang L AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Dai, Qian AU - Dai Q AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Yu, Hua AU - Yu H AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Chen, Qian AU - Chen Q AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Sheng, Halei AU - Sheng H AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Qiu, Jing AU - Qiu J AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - He, Xiaomei AU - He X AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. FAU - Miao, Hongming AU - Miao H AD - Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing 400038, China. FAU - He, Fengtian AU - He F AD - Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing 400038, China. FAU - Zhang, Kebin AU - Zhang K AD - Central Laboratory, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. LA - eng PT - Journal Article DEP - 20190819 PL - Australia TA - J Cancer JT - Journal of Cancer JID - 101535920 PMC - PMC6746116 OTO - NOTNLM OT - KCNQ1DN OT - c-Myc OT - long non-coding RNA OT - renal cell carcinoma COIS- Competing Interests: The authors have declared that no competing interest exists. EDAT- 2019/09/19 06:00 MHDA- 2019/09/19 06:01 PMCR- 2019/01/01 CRDT- 2019/09/19 06:00 PHST- 2018/08/16 00:00 [received] PHST- 2019/05/28 00:00 [accepted] PHST- 2019/09/19 06:00 [entrez] PHST- 2019/09/19 06:00 [pubmed] PHST- 2019/09/19 06:01 [medline] PHST- 2019/01/01 00:00 [pmc-release] AID - jcav10p4662 [pii] AID - 10.7150/jca.29280 [doi] PST - epublish SO - J Cancer. 2019 Aug 19;10(19):4662-4670. doi: 10.7150/jca.29280. eCollection 2019.